Abstract:OBJECTIVE:To investigate serum ghrelin and leptin levels in relation to pathology change of gastric mucous membrane and body mass index (BMI).METHODS:A total of 156 patients were studied from Apr. 2009 to Jul. 2009. Blood serum ghrelin and leptin levels were assessed by ELISA method. All patients underwent gastroscopy with biopsies from gastric antrum and gastric body in order to evaluate pathology change of gastric mucous membrane.RESULTS:Serum ghrelin levels (250.14 ng/L vs 386.65 ng/L) and leptin levels (4.12 μg/L vs 4.31 μg/L) in male subjects were lower than in female ones. There was significant difference in ghrelin levels (P=0.003), but not in leptin levels (P=0.681). ghrelin levels in ≤35-year-old group, 36 to 54-year-old group and ≥55-year-old group were 408.93 ng/L, 309.16 ng/L and 236.76 ng/L respectively, with significant difference (P=0.007). While leptin levels in ≤35-year-old group, 36 to 54-year-old group and ≥55-year-old group were 4.26 μg/L, 4.41 μg/L and 3.86 μg/L respectively, without significant difference (P=0.549). Serum ghrelin levels (308.40 ng/L vs 344.88 ng/L) and leptin levels (4.17 μg/L vs 4.35 μg/L) were both lower in chronic superficial gastritis patients than in chronic atrophy gastritis patients. But no statistically significant difference of ghrelin and leptin levels emerged either in chronic superficial gastritis group or in chronic atrophy gastritis group (P=0.870 and 0.436, respectively). There was a negative correlation between ghrelin and BMI (P=0.000), but a positive correlation between leptin and BMI (P=0.000).CONCLUSION:Gender and age have influence on serum ghrelin levels. Meanwhile, serum ghrelin and leptin levels were associated with neither chronic superficial gastritis nor chronic atrophy gastritis. Serum ghrelin levels decrease and leptin levels increase with the increase of BMI.

Role of Detecting Leptin and Neuropeptid Y Level in Serum of Gastic Cancer Patients

Blood leptin and neuropeptide Y levels in patients with gastric ulcer

New Utility of an Old Marker: Serum Low-Density Lipoprotein Predicts Histopathological Response of Neoadjuvant Chemotherapy in Locally Advanced Gastric Cancer.

Alteration of Serum Leptin and Body Fat in Patients with Gastric Cancer

Hypoleptinemia in Gastric Cancer Patients: Relation to Body Fat Mass, Insulin, and Growth Hormone

The change of leptin in cancer cachexia

Relationship between Serum Leptin Concentration and Nutritional Status of Patients with Gastric Cancer

[Expression of HER-2 and Leptin in Gastric Cancer and Their Clinical Significance].

Expression of growth hormone and its receptor in chronic atrophic gastritis and its clinical significance.

Prognostic role of C-reactive protein in gastric cancer: a meta-analysis.

Serum leptin levels in gastric cancer patients and the relationship with insulin resistance

Study on the Gastic Leptin and Helicobacter Pylori Associated Gastritis

Correlation Between Expression of Leptin and Clinicopathological Features and Prognosis in Patients with Gastric Cancer.

Serum Leptin, Adiponectin and Endometrial Cancer Risk in Chinese Women

Low level of serum high-density lipoprotein cholesterol in gastric cancer correlates with cancer progression but not survival

[Relationship among Pathological Change of Gastric Mucous, Body Mass Index and the Serum Levels of Ghrelin and Leptin].

Changes of Serum IL-6 and Acute-Phase Protein in Gastric Cancer Patients with Weight Loss

[Effect of Serum Leptin on Nutritional Status of Patients with Cancer].

Analysis of the Immunologic Function in Patients with Gastric Cancer

Circulating ghrelin levels in patients with gastric cancer: a systematic review and meta-analysis

Clinical study on effect of Helicobacter py lori infection on levels of IL-6 and IL-8 in serum,gastric juice,and tissues of gastric cancer patients